NCT01165346 2026-03-13
CKNO-HEP
Centre Oscar Lambret
Phase 2 Completed
Clinical Trials
16 trialsNCT06766643 2025-01-09
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06313190 2024-11-18
HSBRT2402
Sun Yat-sen University
Phase 2 Recruiting
NCT06664996 2024-10-30
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
West China Hospital
Phase 2 Recruiting
NCT06592612 2024-09-19
Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06261125 2024-03-12
HSBRT2401
Sun Yat-sen University
Phase 2 Recruiting
NCT02182687 2024-03-05
SBRTvsTACE
Lahey Clinic
Phase 2 Completed
NCT05157451 2023-03-23
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT00914355 2021-10-06
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
University Health Network, Toronto
Phase 2 Completed
NCT04913480 2021-06-04
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
Phase 2 Unknown
NCT01825824 2019-09-20
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Korea Cancer Center Hospital
Phase 2 Unknown
NCT01850368 2019-09-20
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion
Korea Cancer Center Hospital
Phase 2 Completed
NCT01850667 2019-09-20
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Korea Cancer Center Hospital
Phase 2 Completed
NCT02070419 2014-12-02
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01194206 2012-04-18
Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00691691 2012-01-19
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
AHS Cancer Control Alberta
Phase 2 Unknown